S233: AXICABTAGENE CILOLEUCEL AS SECOND-LINE THERAPY FOR LARGE B-CELL LYMPHOMA IN TRANSPLANT-INELIGIBLE PATIENTS: FINAL ANALYSIS OF ALYCANTE, A PHASE 2 LYSA STUDY

Authors: Roch Houot, Emmanuel Bachy, Guillaume Cartron, Francois-Xavier Gros, Franck Morschhauser, Lucie Oberic, Thomas Gastinne, Pierre Feugier, Rémy Duléry, Catherine Thieblemont, Magalie Joris, Fabrice Jardin, Sylvain Choquet, Rene Olivier Casasnovas, Gabriel Brisou, Morgane Cheminant, Jacques Olivier Bay, Francisco Llamas, Cedric Menard, Karin Tarte, Marie-Helene Delfau-Larue, Emmanuel Itti, Clément Bailly, Yassine Al Tabaa, Camille Laurent, Francois Lemonnier

Published: 2023-08-08

DOI: 10.1097/01.hs9.0000967844.56791.ba

Source: Full article

---

Abstract

No abstract found.